The public issue of Biocon India, the leading biotech company, opened today and received excellent response from public. The issue was oversubscribed by four times within ten minutes of opening. The IPO will close on March 18, 2004.
The IPO which is offered through the 100 per cent book building route has been priced between Rs 270 and Rs 315 per share of Rs 5 as face value.